Mazen Noureddin and Ian Rowe join Louise Campbell and Jörn Schattenberg to discuss an important discussion about the roles different NITs will play in the future of NASH diagnosis, treatment and monitoring. Then Louise talks with PBC Foundation CEO Robert Mitchell-Thain about